CD274 and cancer: Similarly, WB analysis was also confirmed that cGAMP and the cGAMP-loaded control nanocarriers promoted PD-L1 expression, whereas the siPDL1-loaded nanocarriers down-regulated PD-L1 expression in both B16F10 cancer cells and melanoma tumors (Fig. 5, E and F).